3-(3-Carboxypropanoyl)-1-[3-(4-octylphenoxy)-2-oxopropyl]indole-5-carboxylic acid

ID: ALA1801024

Chembl Id: CHEMBL1801024

PubChem CID: 25230917

Max Phase: Preclinical

Molecular Formula: C30H35NO7

Molecular Weight: 521.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCc1ccc(OCC(=O)Cn2cc(C(=O)CCC(=O)O)c3cc(C(=O)O)ccc32)cc1

Standard InChI:  InChI=1S/C30H35NO7/c1-2-3-4-5-6-7-8-21-9-12-24(13-10-21)38-20-23(32)18-31-19-26(28(33)15-16-29(34)35)25-17-22(30(36)37)11-14-27(25)31/h9-14,17,19H,2-8,15-16,18,20H2,1H3,(H,34,35)(H,36,37)

Standard InChI Key:  CILKLAAENJJNEQ-UHFFFAOYSA-N

Associated Targets(Human)

PLA2G4A Tchem Cytosolic phospholipase A2 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Por NADPH--cytochrome P450 reductase (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Por NADPH--cytochrome P450 reductase (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.61Molecular Weight (Monoisotopic): 521.2414AlogP: 5.94#Rotatable Bonds: 17
Polar Surface Area: 122.90Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.37CX Basic pKa: CX LogP: 6.29CX LogD: -0.15
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.17Np Likeness Score: -0.37

References

1. Bovens S, Schulze Elfringhoff A, Kaptur M, Reinhardt D, Schäfers M, Lehr M..  (2010)  1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.,  53  (23): [PMID:21067218] [10.1021/jm101094p]
2. Arnsmann M, Hanekamp W, Elfringhoff AS, Lehr M..  (2017)  Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A2α: Effect of substituents at the indole 3-position on activity, solubility, and metabolic stability.,  125  [PMID:27810597] [10.1016/j.ejmech.2016.10.039]

Source